Cart
sales@molnova.com
Pseudolaroside B
CAS No. 906482-63-1
Pseudolaroside B( ——— )
Catalog No. M38251 CAS No. 906482-63-1
Pseudolaroside B is a benzylisoquinoline glycoside that can be isolated from Pseudolarix kaempferi.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePseudolaroside B
-
NoteResearch use only, not for human use.
-
Brief DescriptionPseudolaroside B is a benzylisoquinoline glycoside that can be isolated from Pseudolarix kaempferi.
-
DescriptionPseudolaroside B is a benzylisoquinoline glycoside that can be isolated from Pseudolarix kaempferi.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number906482-63-1
-
Formula Weight330.29
-
Molecular FormulaC14H18O9
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Liu P, et al.?
molnova catalog
related products
-
Bruceoside A
Bruceoside A could be transformed into the potent anticancer component brusatol in vivo, rather than its direct deglycosylated metabolite bruceosin.
-
CCF0058981
CCF0058981 is a SARS-CoV-2 inhibitor with low nanomolar biochemical inhibition and efficacy in cellular models comparable to that of Remdesivir.
-
AK-778-XXMU
AK-778-XXMU is an ID2 antagonist with a KD value of 129 nM.AK-778-XXMU has potential antitumor and anticancer activity and can be used for the study of gliomas.
